T h e ne w e ngl a nd jou r na l o f m e dic i ne n engl j med 362;16 nejm.org april 22, 2010 1492 A cute pancreatitis is the third most common gastrointestinal disorder requiring hospitalization in the United States, with annual costs exceeding $2 billion. 1,2 Necrotizing pancreatitis, which is associated with an 8 to 39% rate of death, develops in approximately 20% of patients. 3 The major cause of death, next to early organ failure, is secondary infection of pancreatic or peripancreatic necrotic tissue, leading to sepsis and multiple organ failure. 4 Secondary infection of necrotic tissue in patients with necrotizing pancreatitis is virtually always an indication for intervention. 3, [5] [6] [7] The traditional approach to the treatment of necrotizing pancreatitis with secondary infection of necrotic tissue is open necrosectomy to completely remove the infected necrotic tissue. 8, 9 This invasive approach is associated with high rates of complications (34 to 95%) and death (11 to 39%) and with a risk of long-term pancreatic insufficiency. [10] [11] [12] [13] [14] [15] [16] As an alternative to open necrosectomy, less invasive techniques, including percutaneous drainage, 17, 18 endoscopic (transgastric) drainage, 19 and minimally invasive retroperitoneal necrosectomy, are increasingly being used. 14, [20] [21] [22] These techniques can be performed in a so-called step-up approach. 23 As compared with open necrosectomy, the step-up approach aims at control of the source of infection, rather than complete removal of the infected necrotic tissue. The first step is percutaneous or endoscopic drainage of the collection of infected fluid to mitigate sepsis; this step may postpone or even obviate surgical necrosectomy. [17] [18] [19] If drainage does not lead to clinical improvement, the next step is minimally invasive retroperitoneal necrosectomy. 14, [20] [21] [22] The step-up approach may reduce the rates of complications and death by minimizing surgical trauma (i.e., tissue damage and a systemic proinflammatory response) in already critically ill patients. 14, 21 It remains uncertain which intervention in these patients is optimal in terms of clinical outcomes, health care resource utilization, and costs. We performed a nationwide randomized trial called Minimally Invasive Step Up Approach versus Maximal Necrosectomy in Patients with Acute Necrotising Pancreatitis (PANTER).
Me thods

Study Design
The design and rationale of the PANTER study have been described previously. 24 Adults with acute pan-creatitis and signs of pancreatic necrosis, peripancreatic necrosis, or both, as detected on contrast-enhanced computed tomography (CT), were enrolled in 7 university medical centers and 12 large teaching hospitals of the Dutch Pancreatitis Study Group. Patients with confirmed or suspected infected pancreatic or peripancreatic necrosis were eligible for randomization once a decision to perform a surgical intervention had been made and percutaneous or endoscopic drainage of the fluid collection was deemed possible.
Infected necrotic tissue was defined as a positive culture of pancreatic or peripancreatic necrotic tissue obtained by means of fine-needle aspiration or from the first drainage procedure or operation, or the presence of gas in the fluid collection on contrast-enhanced CT. Suspected infected necrosis was defined as persistent sepsis or progressive clinical deterioration despite maximal support in the intensive care unit (ICU), without documentation of infected necrosis.
The exclusion criteria were a flare-up of chronic pancreatitis, previous exploratory laparotomy during the current episode of pancreatitis, previous drainage or surgery for confirmed or suspected infected necrosis, pancreatitis caused by abdominal surgery, and an acute intraabdominal event (e.g., perforation of a visceral organ, bleeding, or the abdominal compartment syndrome).
Patients were randomly assigned to either primary open necrosectomy or the minimally invasive step-up approach. Randomization was performed centrally by the study coordinator. Permuted-block randomization was used with a concealed block size of four. Randomization was stratified according to the treatment center and the access route that could be used for drainage (i.e., a retroperitoneal route or only a transabdominal or endoscopic transgastric route).
Study Oversight
All patients or their legal representatives provided written informed consent before randomization. This investigator-initiated study was conducted in accordance with the principles of the Declaration of Helsinki. The institutional review board of each participating hospital approved the protocol.
Quality Control
The indication for intervention and the optimal timing of intervention in necrotizing pancreatitis are frequently subject to discussion. 25 Therefore, an expert panel consisting of eight gastrointesti-nal surgeons, one gastroenterologist, and three radiologists was formed. Whenever infected necrosis was suspected or there was any other indication for intervention in a patient, the expert panel received a case description, including CT images, on a standardized form by e-mail. Within 24 hours, the members of the expert panel individually assessed the indication for intervention and the patient's eligibility for randomization.
Whenever possible, the randomization and intervention were postponed until approximately 4 weeks after the onset of disease. 5, 6, 26, 27 All interventions were performed by gastrointestinal surgeons who were experienced in pancreatic surgery and by experienced interventional radiologists and endoscopists. Whenever necessary, the most experienced study clinicians visited the participating centers to assist with interventions.
Open Necrosectomy
The open necrosectomy, originally described by Beger et al., 8 consisted of a laparotomy through a bilateral subcostal incision. After blunt removal of all necrotic tissue, two large-bore drains for postoperative lavage were inserted, and the abdomen was closed.
Minimally Invasive Step-up Approach
The first step was percutaneous or endoscopic transgastric drainage. The preferred route was through the left retroperitoneum, thereby facilitating minimally invasive retroperitoneal necrosectomy at a later stage, if necessary. If there was no clinical improvement (according to prespecified criteria 24 ) after 72 hours and if the position of the drain (or drains) was inadequate or other fluid collections could be drained, a second drainage procedure was performed. If this was not possible, or if there was no clinical improvement after an additional 72 hours, the second step, videoassisted retroperitoneal débridement (VARD) with postoperative lavage, 21, 22 was performed. (Details on the step-up approach and postoperative management in both groups are included in the Supplementary Appendix, available with the full text of this article at NEJM.org.)
End Points and Data Collection
The predefined primary end point was a composite of major complications (i.e., new-onset multiple organ failure or systemic complications, enterocutaneous fistula or perforation of a visceral organ requiring intervention, or intraabdominal bleeding requiring intervention) (Table 1) or death during admission or during the 3 months after discharge. The individual components of the primary end point were analyzed as secondary end points. Secondary end points also included other complications (Table 1) , health care resource utilization, and total direct medical costs and indirect costs from admission until 6 months after discharge (details are available in the Supplementary Appendix).
Follow-up visits took place 3 and 6 months after discharge. Data collection was performed by local physicians using Internet-based case-record forms. An independent auditor who was unaware of the treatment assignments checked all completed case-record forms against on-site source data. Discrepancies detected by the auditor were resolved on the basis of a consensus by two investigators who were unaware of the study-group assignments and were not involved in patient care. All CT scans were prospectively evaluated by one experienced radiologist who was unaware of the treatment assignments and outcomes.
A blinded outcome assessment was performed by an adjudication committee consisting of eight experienced gastrointestinal surgeons who independently reviewed all data regarding complications. Disagreements were resolved during a plenary consensus meeting with concealment of the treatment assignments.
Statistical Analysis
We calculated that we would need to enroll 88 patients 24 in order to detect a 64% relative reduction in the rate of the composite primary end point with the step-up approach (from 45% to 16%), with a power of 80% and a two-sided alpha level of 0.05. The large risk reduction with the step-up approach was expected on the basis of results from a Dutch nationwide retrospective multicenter study 30 and other previous studies. 17, 31 Moreover, a larger sample was not thought to be feasible because necrotizing pancreatitis with secondary infection is uncommon.
All analyses were performed according to the intention-to-treat principle. The occurrences of the primary and secondary end points were compared between the treatment groups. Results are presented as risk ratios with corresponding 95% confidence intervals. Differences in other outcomes were assessed with the use of the Mann-Whitney U test.
Predefined subgroup analyses were performed for the presence or absence of organ failure at randomization and the timing of intervention (≤28 days or >28 days after the onset of symptoms).
A formal test of interaction in a logistic-regression model was used to assess whether treatment effects differed significantly between the subgroups. No interim analysis was performed. As a precautionary measure, an independent biostatistician who was unaware of the study-group assignments performed sequential monitoring 32 of the major complications and deaths reported during the trial (details are available in the Supplementary Appendix).
All reported P values are two-sided and have not been adjusted for multiple testing.
R esult s
Study Participants
Between November 3, 2005, and October 29, 2008, a total of 378 patients with acute pancreatitis who had signs of pancreatic necrosis, peripancreatic necrosis, or both were enrolled in the study. A total of 88 patients were randomly assigned to a treatment group (Fig. 1) . Baseline characteristics of the treatment groups were similar ( Table 2) .
Primary Open Necrosectomy
Of the 45 patients assigned to primary open necrosectomy, 44 underwent a primary laparotomy. In one patient, who had previously undergone esophagectomy, it was decided after randomization that laparotomy would potentially compromise the gastric conduit. Therefore, primary VARD without previous percutaneous drainage was performed.
Patients underwent a median of 1 open necrosectomy (range, 1 to 7). Nineteen patients (42%) required one or more additional laparotomies for additional necrosectomy because of ongoing sepsis (in eight patients), complications (in five patients) or both (in six patients (33%) required additional percutaneous drainage after laparotomy.
Minimally Invasive Step-up Approach
Forty of 43 patients assigned to the step-up approach (93%) underwent retroperitoneal percutaneous drainage; 1 patient (2%) underwent trans- neous or endoscopic drainage only, without the need for necrosectomy. The condition of two patients with progressive multiple organ failure was too unstable for surgery, and they subsequently died. The remaining 26 patients (60%) underwent necrosectomy a median of 10 days (range, 1 to 52) after percutaneous drainage. A VARD procedure was performed in 24 of the patients, and the other 2 patients underwent primary laparotomy accord-ing to the protocol because there was no retroperitoneal access route. A median of 1 VARD procedure (range, 0 to 3) was performed in each patient. In one patient, VARD was intraoperatively converted to laparotomy because it was not possible to reach the pancreatic necrosis through the retroperitoneum. Fourteen patients (33%) required one or more additional operations for further necrosectomy (five patients), complications (seven patients), or both (two patients). Seven of the 26 patients who underwent necrosectomy (27%) required percutaneous drainage afterward.
Clinical End Points
The primary and secondary end points are listed in Table 3 . The composite primary end point of major complications or death occurred in 31 of 45 patients after primary open necrosectomy (69%) and in 17 of 43 patients after the step-up approach (40%) (risk ratio with the step-up approach, 0.57; 95% confidence interval [CI], 0.38 to 0.87; P = 0.006). All major complications tended to occur more frequently after primary open necrosectomy than after the step-up approach, although the difference was significant only for the composite end point of new-onset multiple organ failure or multiple systemic complications (P = 0.001). This difference was mainly driven by the occurrence of organ failure (Table 3) . The rate of death between the two study groups did not differ significantly (P = 0.70) (Table 3) At the 6-month follow-up, patients who had undergone primary open necrosectomy, as compared with patients who had been treated with the step-up approach, had a higher rate of incisional hernias (24% vs. 7%, P = 0.03), new-onset diabetes (38% vs. 16%, P = 0.02), and use of pancreatic enzymes (33% vs. 7%, P = 0.002).
Health Care Resource Utilization and Costs
Utilization of health care resources for operations (i.e., necrosectomies and reinterventions for complications) was lower in the group of patients who were treated with the step-up approach than in the group of patients who underwent primary open necrosectomy (P = 0.004) (Table 3) . After primary open necrosectomy, 40% of patients required a new ICU admission, as compared with 16% of patients who had been treated with the step-up approach (P = 0.01).
The mean total of direct medical costs and indirect costs per patient during admission and at the 6-month follow-up was €78,775 ($116,016) for the step-up approach and €89,614 ($131,979) for open necrosectomy, for a mean absolute difference of €10,839 ($15,963) per patient. Thus, the step-up approach reduced costs by 12% (details of costs are available in the Table in the Supplementary Appendix).
Predefined Subgroup Analyses
Treatment effects with respect to the primary end point were similar across the subgroups on the basis of organ failure at the time of randomization and the timing of intervention (≤28 days or >28 days after the onset of symptoms). None of the tests for interaction were significant (P>0.05).
Discussion
This study showed that the minimally invasive step-up approach, as compared with primary open necrosectomy, reduced the rate of the composite end point of major complications or death, as well as long-term complications, health care resource utilization, and total costs, among patients who had necrotizing pancreatitis and confirmed or suspected secondary infection. With the step-up approach, more than one third of patients were successfully treated with percutaneous drainage and did not require major abdominal surgery.
There are several possible explanations for the favorable outcome of the step-up approach. First, as we postulated when designing the study, 24 infected necrosis may be similar to an abscess because both contain infected fluid (pus) under pressure. Although a true abscess is more easily resolved with percutaneous drainage because it is composed entirely of liquid, simple drainage may also be sufficient to treat infected necrotic tissue. After the infected fluid is drained, the pancreatic necrosis can be left in situ, an approach that is similar to the treatment of necrotizing pancreatitis without infection. This hypothesis apparently holds true, since 35% of our patients who were treated with the step-up approach did not require necrosectomy.
Second, it has been suggested that minimally invasive techniques provoke less surgical trauma Our findings are consistent with observations from several retrospective studies. It has been suggested previously that percutaneous drainage can be performed in almost every patient who has necrotizing pancreatitis with infection and obviates the need for necrosectomy in approximately half the patients. 17, 18, 33 Several authors have reported promising results of minimally invasive necrosectomy, 14, 20, 22 including endoscopic procedures. 19, [34] [35] [36] Most studies, however, included only a small number of patients and may have unintentionally selected patients who were less ill than the patients treated with open necrosectomy or were better candidates for minimally invasive techniques. In contrast, the current study was randomized and included a relatively large number of patients, with a high incidence of confirmed infected necrotic tissue and organ failure at the time of intervention.
The benefit of the step-up approach in terms of preventing major abdominal surgery and associated complications, such as multiple organ failure requiring ICU admission, is of obvious importance. The reduction in long-term complications, including new-onset diabetes and incisional hernias, is also clinically relevant. Diabetes due to necrotizing pancreatitis is known to worsen over time. 15 Moreover, secondary complications from diabetes have a considerable effect on the quality of life and potentially on life expectancy. Incisional hernias often cause disabling discomfort and pain, carry a risk of small-bowel strangulation, and frequently require surgical intervention. 37 Aside from these clinical implications, the estimated economic benefit from reduced health care resource utilization and costs may be substantial. Approximately 233,000 patients are admitted with a new diagnosis of acute pancreatitis in the United States each year, 38 and necrotizing pancreatitis with secondary infection develops in about 5% of these patients. 3, 28 On the basis of these numbers, the step-up approach may reduce annual costs in the United States by $185 million.
The nationwide multicenter setting of our study and the applicability of the minimally invasive techniques provide support for the generalizability of its results. Percutaneous catheter drainage is a relatively easy and well-established radiolo gic procedure. VARD is considered a fairly straightforward procedure that can be performed by any gastrointestinal surgeon with basic laparoscopic skills and experience in pancreatic necrosectomy. 21, 22 Our study specifically compared two treatment strategies and does not provide a direct comparison of open necrosectomy with minimally invasive retroperitoneal necrosectomy. Although there are theoretical advantages of a minimally invasive approach, we have not proved that VARD is superior to open necrosectomy in patients in whom percutaneous drainage has failed.
This study was not designed or powered to demonstrate a difference in the rate of death between the two treatment strategies. A study showing a clinically relevant difference in mortality would require thousands of patients and is not likely to be performed.
Our results indicate that the preferred treatment strategy for patients with necrotizing pancreatitis and secondary infection, from both a clinical and an economic point of view, is a minimally invasive step-up approach consisting of percutaneous drainage followed, if necessary, by minimally invasive retroperitoneal necrosectomy. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.
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